Question 1

Does Ubs own AIM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 28,931 shares of AIM (Aim Immunotech), worth $8,216.

Question 2

How many shares of AIM does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 28,931 shares of AIM (Aim Immunotech).

Question 3

What is Ubs' AIM position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' AIM position is worth $8,216.

Question 4

Is Ubs buying or selling AIM?

Accepted Answer

In Q2 2026, Ubs increased its AIM position from 1 to 28,931 shares.

Question 5

When did Ubs first buy AIM?

Accepted Answer

Ubs first reported AIM in its Q2 2025 13F and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	28,931	+28.9Kx	$8,216	0.0%	$0.28	18
2026-Q1	Decreased	1	-99.7%	$1	0.0%	$0.70	0
2025-Q4	Increased	379	+24.7%	$428	0.0%	$1.22	9
2025-Q3	Decreased	304	-74.3%	$833	0.0%	$2.66	0
2025-Q2	New	1,181	-	$10,216	0.0%	$8.63	26

AIM5 quarters

AIM
5 quarters